dc.contributor.author
Rodríguez, Laura G.
dc.contributor.author
Bonjoch i Sesé, Josep
dc.contributor.author
Bradshaw, Ben
dc.date.issued
2025-04-29T16:35:54Z
dc.date.issued
2025-04-29T16:35:54Z
dc.date.issued
2023-10-23
dc.date.issued
2025-04-29T16:35:54Z
dc.identifier
https://hdl.handle.net/2445/220699
dc.description.abstract
Several natural products, bearing an embedded hexahydro-2,6-methano-1-benzazocine framework (3,4-benzomorphan) – a heterocyclic regioisomer of the 6,7-benzomorphan substructure found in morphine alkaloids, have therapeutic potential for a variety of diseases. Biogenesis, biosynthetic approaches, and total syntheses of alkaloids or synthetic azapolycyclic compounds featuring the aforementioned azatricyclic ring system (i. e., a 3,4-benzomorphan scaffold) are reviewed.
dc.format
application/pdf
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/ejoc.202300689
dc.relation
European Journal of Organic Chemistry, 2023
dc.relation
https://doi.org/10.1002/ejoc.202300689
dc.rights
cc-by-nc-nd (c) Rodríguez et al., 2023
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Síntesi orgànica
dc.subject
Ciclització (Química)
dc.subject
Organic synthesis
dc.subject
Ring formation (Chemistry)
dc.title
Synthesis of Alkaloids and Compounds Containing the 3,4-Benzomorphan Scaffold
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
